4 Sc AG Stock Xetra
Equities
VSC1k
DE0005753818
Biotechnology & Medical Research
Sales 2022 | 436K 468K | Sales 2023 | 304K 326K | Capitalization | 89.51M 96.05M |
---|---|---|---|---|---|
Net income 2022 | -14M -15.02M | Net income 2023 | -8M -8.58M | EV / Sales 2022 | -4.31 x |
Net cash position 2022 | 14.82M 15.91M | Net cash position 2023 | 5.22M 5.6M | EV / Sales 2023 | 277 x |
P/E ratio 2022 |
-0.9
x | P/E ratio 2023 |
-10.9
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 26.68% |
1st Jan change | Capi. | |
---|---|---|
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.79% | 22.02B | |
-17.84% | 20.9B | |
-11.11% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |